Alnylam Pharmaceuticals
ALNY
#443
Rank
S$68.34 B
Marketcap
S$517.30
Share price
1.06%
Change (1 day)
59.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company